Goldman Sachs’s Immunomedics Inc IMMU Stock Holding History

Goldman Sachs’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-23,200	Closed	-$1.97M	–	5880
2020 Q3	$1.97M	Hold	23,200	–	–	﹤0.01%	3573
2020 Q2	$822K	Buy	+23,200	New	+$678K	﹤0.01%	4088
2018 Q2	–	Sell	-58,400	Closed	-$853K	–	6166
2018 Q1	$853K	Hold	58,400	–	–	﹤0.01%	4148
2017 Q4	$944K	Buy	+58,400	New	+$689K	﹤0.01%	4365
2015 Q3	–	Sell	-82,400	Closed	-$335K	–	7576
2015 Q2	$335K	Sell	82,400 -120,100	-59%	-$491K	﹤0.01%	5633
2015 Q1	$776K	Buy	+202,500	New	+$881K	﹤0.01%	4708

Goldman Sachs's IMMU Position: Q4 2020 in Review

Goldman Sachs sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 4,916,448 shares — an estimated $418M sold.

Goldman Sachs first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $418M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Goldman Sachs reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Goldman Sachs sold 4,916,448 Immunomedics Inc shares in Q4 2020, an estimated $418M.
Goldman Sachs first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
Goldman Sachs's Immunomedics Inc position peaked at $418M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.